MedPath

Fluphenazine Hydrochloride

Fluphenazine Hydrochloride Oral Solution USP (Concentrate)

Approved
Approval ID

0860b3f3-3116-40f8-bcb0-e5c47731bdc8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 11, 2022

Manufacturers
FDA

Pharmaceutical Associates, Inc.

DUNS: 044940096

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluphenazine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0121-0653
Application NumberANDA074725
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fluphenazine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 11, 2022
FDA Product Classification

INGREDIENTS (5)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
FLUPHENAZINE HYDROCHLORIDEActive
Quantity: 5 mg in 1 mL
Code: ZOU145W1XL
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.